Correlation Between NovaBay Pharmaceuticals and VivoSim Labs,
Can any of the company-specific risk be diversified away by investing in both NovaBay Pharmaceuticals and VivoSim Labs, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NovaBay Pharmaceuticals and VivoSim Labs, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NovaBay Pharmaceuticals and VivoSim Labs,, you can compare the effects of market volatilities on NovaBay Pharmaceuticals and VivoSim Labs, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NovaBay Pharmaceuticals with a short position of VivoSim Labs,. Check out your portfolio center. Please also check ongoing floating volatility patterns of NovaBay Pharmaceuticals and VivoSim Labs,.
Diversification Opportunities for NovaBay Pharmaceuticals and VivoSim Labs,
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between NovaBay and VivoSim is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding NovaBay Pharmaceuticals and VivoSim Labs, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VivoSim Labs, and NovaBay Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NovaBay Pharmaceuticals are associated (or correlated) with VivoSim Labs,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VivoSim Labs, has no effect on the direction of NovaBay Pharmaceuticals i.e., NovaBay Pharmaceuticals and VivoSim Labs, go up and down completely randomly.
Pair Corralation between NovaBay Pharmaceuticals and VivoSim Labs,
Considering the 90-day investment horizon NovaBay Pharmaceuticals is expected to generate 1.18 times more return on investment than VivoSim Labs,. However, NovaBay Pharmaceuticals is 1.18 times more volatile than VivoSim Labs,. It trades about 0.01 of its potential returns per unit of risk. VivoSim Labs, is currently generating about -0.02 per unit of risk. If you would invest 152.00 in NovaBay Pharmaceuticals on September 9, 2025 and sell it today you would lose (29.00) from holding NovaBay Pharmaceuticals or give up 19.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NovaBay Pharmaceuticals vs. VivoSim Labs,
Performance |
| Timeline |
| NovaBay Pharmaceuticals |
| VivoSim Labs, |
NovaBay Pharmaceuticals and VivoSim Labs, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NovaBay Pharmaceuticals and VivoSim Labs,
The main advantage of trading using opposite NovaBay Pharmaceuticals and VivoSim Labs, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NovaBay Pharmaceuticals position performs unexpectedly, VivoSim Labs, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VivoSim Labs, will offset losses from the drop in VivoSim Labs,'s long position.The idea behind NovaBay Pharmaceuticals and VivoSim Labs, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| VivoSim Labs, vs. Quoin Pharmaceuticals Ltd | VivoSim Labs, vs. Pasithea Therapeutics Corp | VivoSim Labs, vs. Cyclerion Therapeutics | VivoSim Labs, vs. Alaunos Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |